Phase I/IIA Study with CNS-Targeted Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (BM) From Breast Cancer (BC) and Other Brain Tumors

P. G. Aftimos; V. Diéras; S. Altintas; C. Anders; M. Arnedos; A. Gelderblom; P. Soetekouw; A. Jager; M. van Linde; D. Brandsma

doi:10.1093/annonc/mdu071.2

Phase I/IIA Study with CNS-Targeted Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (BM) From Breast Cancer (BC) and Other Brain Tumors

P. G. Aftimos
, V. Diéras
, S. Altintas
, C. Anders
, M. Arnedos
, A. Gelderblom
, P. Soetekouw
, A. Jager
, M. van Linde
, D. Brandsma

Affiliatie VU

Université libre de Bruxelles
Institut Curie
University of Antwerp
University of North Carolina at Chapel Hill
Institut Gustave Roussy
Leiden University
Maastricht University
Erasmus University Rotterdam
Antoni van Leeuwenhoek Hospital

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	i25
Journal	Annals of oncology
Volume	25
DOIs	https://doi.org/10.1093/annonc/mdu071.2
Publication status	Published - May 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/annonc/mdu071.2

Cite this

Aftimos, P. G., Diéras, V., Altintas, S., Anders, C., Arnedos, M., Gelderblom, A., Soetekouw, P., Jager, A., van Linde, M., & Brandsma, D. (2014). Phase I/IIA Study with CNS-Targeted Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (BM) From Breast Cancer (BC) and Other Brain Tumors. Annals of oncology, 25, i25. https://doi.org/10.1093/annonc/mdu071.2

@article{a6c71ca5e720403bb8c4377bee073bd3,

title = "Phase I/IIA Study with CNS-Targeted Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (BM) From Breast Cancer (BC) and Other Brain Tumors",

author = "Aftimos, \{P. G.\} and V. Di{\'e}ras and S. Altintas and C. Anders and M. Arnedos and A. Gelderblom and P. Soetekouw and A. Jager and \{van Linde\}, M. and D. Brandsma",

year = "2014",

month = may,

doi = "10.1093/annonc/mdu071.2",

language = "English",

volume = "25",

pages = "i25",

journal = "Annals of oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Phase I/IIA Study with CNS-Targeted Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (BM) From Breast Cancer (BC) and Other Brain Tumors

AU - Aftimos, P. G.

AU - Diéras, V.

AU - Altintas, S.

AU - Anders, C.

AU - Arnedos, M.

AU - Gelderblom, A.

AU - Soetekouw, P.

AU - Jager, A.

AU - van Linde, M.

AU - Brandsma, D.

PY - 2014/5

Y1 - 2014/5

UR - https://www.scopus.com/pages/publications/85083347299

U2 - 10.1093/annonc/mdu071.2

DO - 10.1093/annonc/mdu071.2

M3 - Article

SN - 0923-7534

VL - 25

SP - i25

JO - Annals of oncology

JF - Annals of oncology

ER -

Phase I/IIA Study with CNS-Targeted Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (BM) From Breast Cancer (BC) and Other Brain Tumors

UN SDGs

Access to Document

Other files and links

Cite this